<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862347</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.493</article-id><article-id pub-id-type="other">EPP0316</article-id><article-id pub-id-type="pii">S0924933824004930</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Bouchet</surname><given-names>L.</given-names></name><xref rid="aff1094" ref-type="aff">
<sup>1</sup></xref><xref rid="aff1095" ref-type="aff">
<sup>2</sup></xref><xref rid="cor0354" ref-type="corresp">
<sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sager</surname><given-names>Z.</given-names></name><xref rid="aff1096" ref-type="aff">
<sup>3</sup></xref><xref rid="aff1097" ref-type="aff">
<sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yrondi</surname><given-names>A.</given-names></name><xref rid="aff1094" ref-type="aff">
<sup>1</sup></xref><xref rid="aff1095" ref-type="aff">
<sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kabir</surname><given-names>N.</given-names></name><xref rid="aff1098" ref-type="aff">
<sup>5</sup></xref><xref rid="aff1099" ref-type="aff">
<sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>B.</given-names></name><xref rid="aff1100" ref-type="aff">
<sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ross</surname><given-names>S.</given-names></name><xref rid="aff1101" ref-type="aff">
<sup>8</sup></xref><xref rid="aff1102" ref-type="aff">
<sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Petridis</surname><given-names>P.</given-names></name><xref rid="aff1101" ref-type="aff">
<sup>8</sup></xref><xref rid="aff1102" ref-type="aff">
<sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Beaussant</surname><given-names>Y.</given-names></name><xref rid="aff1096" ref-type="aff">
<sup>3</sup></xref><xref rid="aff1097" ref-type="aff">
<sup>4</sup></xref></contrib></contrib-group><aff id="aff1094">
<sup>1</sup>Psychiatry and Medical Psychotherapy, <institution>CHU de Toulouse</institution>
</aff><aff id="aff1095">
<sup>2</sup>Psychiatry and Medical Psychotherapy, <institution>Universit&#x000e9; Paul Sabatier Toulouse III - Facult&#x000e9; de M&#x000e9;decine Purpan</institution>, <city>Toulouse</city>, <country>France</country>
</aff><aff id="aff1096">
<sup>3</sup>Psycho-oncology and Palliative Care, <institution>Dana Farber Cancer Institute</institution>
</aff><aff id="aff1097">
<sup>4</sup>Psycho-oncology and Palliative Care, <institution>Harvard Medical School</institution>
</aff><aff id="aff1098">
<sup>5</sup>Psychiatry, <institution>Brigham and Women&#x02019;s Hospital</institution>
</aff><aff id="aff1099">
<sup>6</sup>Psychiatry, <institution>Harvard Medical School</institution>, <city>Boston</city>
</aff><aff id="aff1100">
<sup>7</sup>Psychiatry and Behavioral Science, <institution>University of California San Francisco School of Medicine</institution>, <city>San Francisco</city>
</aff><aff id="aff1101">
<sup>8</sup>Psychiatry, <institution>
New York University School of Medicine</institution>
</aff><aff id="aff1102">
<sup>9</sup><institution>NYU Langone Center for Psychedelic Medicine, NYU Grossman School of Medicine</institution>, <city>New-York
</city>, <country>United States</country>
</aff><author-notes><corresp id="cor0354">
<label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="468">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S232</fpage><lpage>S232</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824004930a.pdf"/><abstract><sec id="sec2125"><title>Introduction</title><p>Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and post-traumatic stress disorder.</p></sec><sec id="sec2126"><title>Objectives</title><p>The goal of this study was to quantify the prevalence of older adults enrolled in psychedelic clinical trials and explore safety data in this population.</p></sec><sec id="sec2127"><title>Methods</title><p>A systematic review was conducted following the 2020 PRISMA guidelines. Search criteria included all trials published in English using psychedelic substances to treat psychiatric conditions, including addiction as well as existential distress related to serious illness. Articles were identified from literature searches on PubMed, EBSCO and EMBASE.</p></sec><sec id="sec2128"><title>Results</title><p>4,376 manuscripts were identified, of which 505 qualified for further review, with 36 eventually meeting eligibility criteria. Of the 1,400 patients enrolled in the 36 studies, only 19 were identified as 65 or older, representing less than 1.4% of all trial participants. For 10 of these 19 older adults, detailed safety data was obtained. No serious adverse events (AEs) occurred in any older adults and only transient mild-to-moderate AEs related to anxiety, gastrointestinal upset, and hypertension were reported during the psychedelic dosing sessions.</p></sec><sec id="sec2129"><title>Conclusions</title><p>While existing data in older adults is limited, it suggests that psychedelic-assisted psychotherapy is safe and well tolerated in older adults. Therefore, psychedelic-assisted psychotherapy should be more rigorously investigated for the treatment of psychiatric conditions in this population.</p></sec><sec id="sec2130"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>